Metastatic breast cancer in a Nigerian tertiary hospital

被引:0
|
作者
Adisa, A. O. [1 ]
Arowolo, O. A. [1 ]
Akinkuolie, A. A. [1 ]
Titiloye, N. A. [2 ]
Alatise, O., I [1 ]
Lawal, O. O. [1 ]
Adesunkanmi, A. R. K. [1 ]
机构
[1] Obafemi Awolowo Univ, Dept Surg, Coll Hlth Sci, Ife 220005, Osun State, Nigeria
[2] Obafemi Awolowo Univ, Dept Morbid Anat, Coll Hlth Sci, Ife 220005, Osun State, Nigeria
关键词
breast cancer; metastasis; developing country; SURVIVAL; CHEMOTHERAPY; MANAGEMENT; CHALLENGES; PHENOTYPE; WOMEN; RACE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Late presentation of breast carcinoma is common in resource-limited countries with attendant poor outcome. Objective: To describe the pattern of clinical presentation and challenges of treating patients presenting with metastatic breast carcinoma in a Nigerian hospital. Method: Clinical records of all patients who presented with metastatic breast carcinoma between January 1991 and December 2005 at the Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria were reviewed. Results: More than half of all histologically confirmed breast cancer patients seen within the study period presented with metastatic disease. Their ages ranged between 20-81years with a mean age of 45.9 years. Only 3% (6 of 202) were males. Two-thirds had more than one secondary site on initial evaluation and the commonest sites were liver (63%), lung parenchyma (51%), pleura (26%) and contralateral breast in 25%. On immunohistochemistry, basal like tumours were found in 46.1%. Mastectomy was done in 37 patients with fungating breast masses while only one third of those referred to a nearby center for radiotherapy had it done. One year survival rate was 27%. Conclusion: Metastatic disease is common in Nigeria and treatment is limited due to resource limitations. Improved awareness of the disease is advocated to reduce late presentation.
引用
收藏
页码:279 / 284
页数:6
相关论文
共 50 条
  • [41] Variation in hospital treatment patterns for metastatic colorectal cancer
    Krell, Robert W.
    Regenbogen, Scott E.
    Wong, Sandra L.
    CANCER, 2015, 121 (11) : 1755 - 1761
  • [42] Clinicopathological Features and Metastatic Pattern of Triple-positive Breast Cancer Among Female Patients at a Tertiary Care Hospital
    Alzahrani, Walaa
    Althoubaity, Fatma
    Alsobhi, Dur
    Mohamed, Yasmina
    AlMutairi, Amani
    Sindi, Dalia
    Alharbi, Rasha
    Zaidi, Nisar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (12)
  • [43] Eribulin Monotherapy in Patients Aged 70 Years and Older With Metastatic Breast Cancer
    Muss, Hyman
    Cortes, Javier
    Vahdat, Linda T.
    Cardoso, Fatima
    Twelves, Chris
    Wanders, Jantien
    Dutcus, Corina E.
    Yang, Jay
    Seegobin, Seth
    O'Shaughnessy, Joyce
    ONCOLOGIST, 2014, 19 (04) : 318 - 327
  • [44] Usefulness of chemotherapy beyond the second line for metastatic breast cancer: a therapeutic challenge
    Vauleon, Elodie
    Mesbah, Habiba
    Laguerre, Brigitte
    Gedouin, Daniel
    Lefeuvre-Plesse, Claudia
    Leveque, Jean
    Audrain, Odile
    Kerbrat, Pierre
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (01) : 113 - 120
  • [45] Health-related Quality of Life in Metastatic and Adjuvant Breast Cancer Patients
    Wallwiener, M.
    Simoes, E.
    Sokolov, A. N.
    Brucker, S. Y.
    Fasching, P. A.
    Graf, J.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2016, 76 (10) : 1065 - 1073
  • [46] Brain metastatic breast cancer: Epidemiology, survival and prognosis: Single center experience
    Awny, Shadi
    Metwally, Islam H.
    Zuhdy, Mohammad
    Hamdy, Omar
    Mohamed, Laila A.
    Abdelmoety, Zeinab F.
    Elberashi, Hanan M.
    Alghandour, Reham
    Emarah, Ziad
    Elnahas, Waleed
    Abdelwahab, Khaled
    REVISTA DE SENOLOGIA Y PATOLOGIA MAMARIA, 2021, 34 (03): : 156 - 162
  • [47] Chemotherapy use near the end-of-life in patients with metastatic breast cancer
    Kessler, Luisa Edman
    Sigfridsson, Johnny
    Hatzidaki, Dora
    Bergh, Jonas
    Foukakis, Theodoros
    Georgoulias, Vasilios
    Matikas, Alexios
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 181 (03) : 645 - 651
  • [48] Immunohistochemical Markers in Breast Cancer: A Cross-Sectional Study on Triple-Negative Breast Cancer in a Rural Tertiary Care Hospital
    Rakesh, B. A.
    Karanam, Venkata Pavan Kumar
    Mundada, Ashishkumar B.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)
  • [49] Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women
    Agboola, A. J.
    Musa, A. A.
    Wanangwa, N.
    Abdel-Fatah, T.
    Nolan, C. C.
    Ayoade, B. A.
    Oyebadejo, T. Y.
    Banjo, A. A.
    Deji-Agboola, A. M.
    Rakha, E. A.
    Green, A. R.
    Ellis, I. O.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 135 (02) : 555 - 569
  • [50] Breast cancer metastatic to the vulva
    Sheen-Chen, SM
    Eng, HL
    Huang, CC
    GYNECOLOGIC ONCOLOGY, 2004, 94 (03) : 858 - 860